Avai Bio (AVAI) Shares Outstanding (2020 - 2026)

Avai Bio has reported Shares Outstanding (Entity) for 9 years, with the latest figure at $153.2 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 11.54% year-over-year to $153.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $153.2 million (up 11.54% YoY) and the FY2026 annual result came in at $153.2 million, up 11.54% from the prior year.
• Shares Outstanding (Entity) improved to $153.2 million in Q1 2026 per AVAI's latest filing, from $138.0 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $153.2 million in Q1 2026 and troughed at $26.3 million in Q1 2022.
• A 5-year average of $90.2 million and a median of $86.5 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) changed 0.0% in 2022, then soared 222.22% in 2023.
• Over 5 years, Shares Outstanding (Entity) stood at $26.3 million in 2022, then jumped by 222.22% to $84.8 million in 2023, then jumped by 61.72% to $137.1 million in 2024, then increased by 0.66% to $138.0 million in 2025, then rose by 11.0% to $153.2 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $153.2 million, $138.0 million, and $137.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.